The FDA has also given TRIKAFTA approval for use in kids with cystic fibrosis.

Published Date: 05 May 2023

The Food and Drug Administration has extended the indications for elexacaftor, tezacaftor, and ivacaftor (Trikafta) in cystic fibrosis to include even.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

After targeted agents, a novel bispecific in EGFR-mutant lung cancer improves PFS.

2.

Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

3.

Novel biomarker has potential for predicting and treating skin cancer metastasis

4.

Prostate Cancer Treatment Associated With Long-Term Complications

5.

Parkinson patient's gait is restored by a spinal cord stimulator.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot